ArticleAmerican journal of translational research2017

Fisetin suppresses malignant proliferation in human oral squamous cell carcinoma through inhibition of Met/Src signaling pathways.

Yan-Shu Li et al.PubMed ↗Full text ↗

No numbers read from the abstract.